ImmunomeInc Short Long Term Debt vs Non Current Liabilities Total Analysis
IMNM Stock | USD 14.94 0.23 1.56% |
ImmunomeInc financial indicator trend analysis is infinitely more than just investigating ImmunomeInc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmunomeInc is a good investment. Please check the relationship between ImmunomeInc Short Long Term Debt and its Non Current Liabilities Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunomeInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.
Short Long Term Debt vs Non Current Liabilities Total
Short Long Term Debt vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ImmunomeInc Short Long Term Debt account and Non Current Liabilities Total. At this time, the significance of the direction appears to have pay attention.
The correlation between ImmunomeInc's Short Long Term Debt and Non Current Liabilities Total is -0.94. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of ImmunomeInc, assuming nothing else is changed. The correlation between historical values of ImmunomeInc's Short Long Term Debt and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of ImmunomeInc are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Short Long Term Debt i.e., ImmunomeInc's Short Long Term Debt and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | -0.94 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Short Long Term Debt
The total of a company’s short-term and long-term borrowings.Non Current Liabilities Total
Most indicators from ImmunomeInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmunomeInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunomeInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.At this time, ImmunomeInc's Selling General Administrative is very stable compared to the past year. As of the 2nd of June 2024, Enterprise Value is likely to grow to about 121.1 M, while Issuance Of Capital Stock is likely to drop about 29.1 K.
2021 | 2023 | 2024 (projected) | Depreciation And Amortization | 503K | 728K | 689.9K | Interest Income | 5K | 2.7M | 2.9M |
ImmunomeInc fundamental ratios Correlations
Click cells to compare fundamentals
ImmunomeInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ImmunomeInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 5.1M | 44.5M | 57.9M | 24.0M | 148.5M | 156.0M | |
Short Long Term Debt Total | 564K | 613K | 317K | 293K | 1.7M | 845.7K | |
Other Current Liab | 666K | 1.4M | 6.7M | 4.6M | 7.7M | 3.9M | |
Total Current Liabilities | 1.7M | 3.0M | 9.7M | 7.3M | 21.8M | 22.9M | |
Total Stockholder Equity | (35.6M) | 41.3M | 48.2M | 16.7M | 119.9M | 125.9M | |
Net Tangible Assets | (35.6M) | 41.3M | 48.2M | 16.7M | 19.2M | 10.0M | |
Property Plant And Equipment Net | 1.7M | 1.5M | 855K | 965K | 3.6M | 2.0M | |
Net Debt | (2.0M) | (39.2M) | (48.9M) | (20.0M) | (97.0M) | (92.2M) | |
Retained Earnings | (36.6M) | (54.4M) | (79.1M) | (116.0M) | (222.8M) | (211.7M) | |
Accounts Payable | 548K | 1.2M | 3.1M | 2.4M | 3.3M | 2.0M | |
Cash | 2.5M | 39.8M | 49.2M | 20.3M | 98.7M | 103.6M | |
Non Current Assets Total | 1.9M | 1.6M | 1.3M | 1.4M | 3.8M | 2.3M | |
Cash And Short Term Investments | 2.5M | 39.8M | 49.2M | 20.3M | 138.1M | 145.0M | |
Common Stock Shares Outstanding | 5.7M | 3.4M | 11.5M | 12.1M | 19.8M | 10.5M | |
Liabilities And Stockholders Equity | 5.1M | 44.5M | 57.9M | 24.0M | 148.5M | 156.0M | |
Non Current Liabilities Total | 39.0M | 142K | 12K | 62K | 6.8M | 9.9M | |
Capital Lease Obligations | 239K | 0.0 | 317K | 293K | 1.7M | 1.7M | |
Other Current Assets | 579K | 3.1M | 7.4M | 2.3M | 6.3M | 3.7M | |
Other Stockholder Equity | 927K | 95.7M | 127.3M | 132.7M | 342.7M | 359.8M | |
Total Liab | 40.7M | 3.2M | 9.7M | 7.4M | 28.7M | 15.9M | |
Net Invested Capital | (35.3M) | 42.0M | 48.2M | 16.7M | 119.9M | 125.9M | |
Property Plant And Equipment Gross | 1.7M | 1.5M | 3.9M | 681K | 7.5M | 7.9M | |
Total Current Assets | 3.1M | 42.9M | 56.6M | 22.6M | 144.7M | 151.9M | |
Accumulated Other Comprehensive Income | (38.9M) | (44.5M) | (57.9M) | 0.0 | 22K | 23.1K | |
Net Working Capital | 1.5M | 39.9M | 46.9M | 15.3M | 122.9M | 129.0M | |
Short Term Debt | 451K | 479K | 317K | 293K | 310K | 328.3K | |
Property Plant Equipment | 1.7M | 1.5M | 855K | 681K | 612.9K | 1.1M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ImmunomeInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunomeInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for ImmunomeInc Stock analysis
When running ImmunomeInc's price analysis, check to measure ImmunomeInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunomeInc is operating at the current time. Most of ImmunomeInc's value examination focuses on studying past and present price action to predict the probability of ImmunomeInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunomeInc's price. Additionally, you may evaluate how the addition of ImmunomeInc to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is ImmunomeInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunomeInc. If investors know ImmunomeInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunomeInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.58) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.56) | Return On Assets (0.15) | Return On Equity (1.55) |
The market value of ImmunomeInc is measured differently than its book value, which is the value of ImmunomeInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunomeInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunomeInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunomeInc's market value can be influenced by many factors that don't directly affect ImmunomeInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunomeInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunomeInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunomeInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.